This presentation will discuss and review the promise and potential of 3D Microtissues, and the challenges of using these Microtissues as Hazard ID tools. Lastly, we will discuss the potential application of Neural Microtissues in drug discovery screening.
1. Understanding the strengths and limitations of in vitro and in vivo assays for hazard identification and risk assessment.
2. Examining how 3D Microtissues can improve hazard identification in drug discovery, and de-risking during drug development.